A citation-based method for searching scientific literature

Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, Lili Guo, Shannon E McGettigan, Avery D Posey, Prachi R Patel, Sonia Guedan, John Scholler, Brian Keith, Nathaniel W Snyder, Ian A Blair, Michael C Milone, Carl H June. Immunity 2016
Times Cited: 409







List of co-cited articles
1364 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming.
Michael D Buck, David O'Sullivan, Ramon I Klein Geltink, Jonathan D Curtis, Chih-Hao Chang, David E Sanin, Jing Qiu, Oliver Kretz, Daniel Braas, Gerritje J W van der Windt,[...]. Cell 2016
577
9

Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.
Carmine Carpenito, Michael C Milone, Raffit Hassan, Jacqueline C Simonet, Mehdi Lakhal, Megan M Suhoski, Angel Varela-Rohena, Kathleen M Haines, Daniel F Heitjan, Steven M Albelda,[...]. Proc Natl Acad Sci U S A 2009
562
9

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.
James N Kochenderfer, Wyndham H Wilson, John E Janik, Mark E Dudley, Maryalice Stetler-Stevenson, Steven A Feldman, Irina Maric, Mark Raffeld, Debbie-Ann N Nathan, Brock J Lanier,[...]. Blood 2010
820
9

Adoptive cell transfer as personalized immunotherapy for human cancer.
Steven A Rosenberg, Nicholas P Restifo. Science 2015
9

CD19 CAR T cell product and disease attributes predict leukemia remission durability.
Olivia C Finney, Hannah M Brakke, Stephanie Rawlings-Rhea, Roxana Hicks, Danielle Doolittle, Marisa Lopez, Robert B Futrell, Rimas J Orentas, Daniel Li, Rebecca A Gardner,[...]. J Clin Invest 2019
95
9

Mechanisms of resistance to CAR T cell therapy.
Nirali N Shah, Terry J Fry. Nat Rev Clin Oncol 2019
219
9

PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation.
Nikolaos Patsoukis, Kankana Bardhan, Pranam Chatterjee, Duygu Sari, Bianling Liu, Lauren N Bell, Edward D Karoly, Gordon J Freeman, Victoria Petkova, Pankaj Seth,[...]. Nat Commun 2015
477
9

Combined CD28 and 4-1BB Costimulation Potentiates Affinity-tuned Chimeric Antigen Receptor-engineered T Cells.
Esther Drent, Renée Poels, Ruud Ruiter, Niels W C J van de Donk, Sonja Zweegman, Huipin Yuan, Joost de Bruijn, Michel Sadelain, Henk M Lokhorst, Richard W J Groen,[...]. Clin Cancer Res 2019
51
17

Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations.
Robert Weinkove, Philip George, Nathaniel Dasyam, Alexander D McLellan. Clin Transl Immunology 2019
93
9


KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
Michael Wang, Javier Munoz, Andre Goy, Frederick L Locke, Caron A Jacobson, Brian T Hill, John M Timmerman, Houston Holmes, Samantha Jaglowski, Ian W Flinn,[...]. N Engl J Med 2020
268
9

IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo.
Mythili Koneru, Terence J Purdon, David Spriggs, Susmith Koneru, Renier J Brentjens. Oncoimmunology 2015
202
8

Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling.
Scott Wilkie, May C I van Schalkwyk, Steve Hobbs, David M Davies, Sjoukje J C van der Stegen, Ana C Parente Pereira, Sophie E Burbridge, Carol Box, Suzanne A Eccles, John Maher. J Clin Immunol 2012
268
8

Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors.
Leonardo Morsut, Kole T Roybal, Xin Xiong, Russell M Gordley, Scott M Coyle, Matthew Thomson, Wendell A Lim. Cell 2016
338
8

Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.
Waleed Haso, Daniel W Lee, Nirali N Shah, Maryalice Stetler-Stevenson, Constance M Yuan, Ira H Pastan, Dimiter S Dimitrov, Richard A Morgan, David J FitzGerald, David M Barrett,[...]. Blood 2013
334
8

IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8+ T Cell Longevity.
Guoliang Cui, Matthew M Staron, Simon M Gray, Ping-Chih Ho, Robert A Amezquita, Jingxia Wu, Susan M Kaech. Cell 2015
173
8



Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice.
Xiaojun Liu, Shuguang Jiang, Chongyun Fang, Shiyu Yang, Devvora Olalere, Edward C Pequignot, Alexandria P Cogdill, Na Li, Melissa Ramones, Brian Granda,[...]. Cancer Res 2015
237
8

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.
David T Teachey, Simon F Lacey, Pamela A Shaw, J Joseph Melenhorst, Shannon L Maude, Noelle Frey, Edward Pequignot, Vanessa E Gonzalez, Fang Chen, Jeffrey Finklestein,[...]. Cancer Discov 2016
483
8

T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.
Antonio Di Stasi, Biagio De Angelis, Cliona M Rooney, Lan Zhang, Aruna Mahendravada, Aaron E Foster, Helen E Heslop, Malcolm K Brenner, Gianpietro Dotti, Barbara Savoldo. Blood 2009
320
8

Molecular and cellular insights into T cell exhaustion.
E John Wherry, Makoto Kurachi. Nat Rev Immunol 2015
8

Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors.
R Monjezi, C Miskey, T Gogishvili, M Schleef, M Schmeer, H Einsele, Z Ivics, M Hudecek. Leukemia 2017
98
8

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells.
Levi J Rupp, Kathrin Schumann, Kole T Roybal, Rachel E Gate, Chun J Ye, Wendell A Lim, Alexander Marson. Sci Rep 2017
295
8

Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma.
Kevin Bielamowicz, Kristen Fousek, Tiara T Byrd, Hebatalla Samaha, Malini Mukherjee, Nikita Aware, Meng-Fen Wu, Jordan S Orange, Pavel Sumazin, Tsz-Kwong Man,[...]. Neuro Oncol 2018
151
8

Global Manufacturing of CAR T Cell Therapy.
Bruce L Levine, James Miskin, Keith Wonnacott, Christopher Keir. Mol Ther Methods Clin Dev 2016
232
8

A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells.
Martin A Pulè, Karin C Straathof, Gianpietro Dotti, Helen E Heslop, Cliona M Rooney, Malcolm K Brenner. Mol Ther 2005
315
8

Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting.
Shivani Srivastava, Alexander I Salter, Denny Liggitt, Sushma Yechan-Gunja, Megha Sarvothama, Kirsten Cooper, Kimberly S Smythe, Jarrod A Dudakov, Robert H Pierce, Christoph Rader,[...]. Cancer Cell 2019
87
9

Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia.
Nicole E Scharping, Ashley V Menk, Ryan D Whetstone, Xue Zeng, Greg M Delgoffe. Cancer Immunol Res 2017
189
8

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy.
Spencer C Wei, Colm R Duffy, James P Allison. Cancer Discov 2018
961
8

Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma.
Peter J Siska, Kathryn E Beckermann, Frank M Mason, Gabriela Andrejeva, Allison R Greenplate, Adam B Sendor, Yun-Chen J Chiang, Armando L Corona, Lelisa F Gemta, Benjamin G Vincent,[...]. JCI Insight 2017
127
8

Posttranscriptional control of T cell effector function by aerobic glycolysis.
Chih-Hao Chang, Jonathan D Curtis, Leonard B Maggi, Brandon Faubert, Alejandro V Villarino, David O'Sullivan, Stanley Ching-Cheng Huang, Gerritje J W van der Windt, Julianna Blagih, Jing Qiu,[...]. Cell 2013
8

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.
Richard V Parry, Jens M Chemnitz, Kenneth A Frauwirth, Anthony R Lanfranco, Inbal Braunstein, Sumire V Kobayashi, Peter S Linsley, Craig B Thompson, James L Riley. Mol Cell Biol 2005
8

Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.
C Imai, K Mihara, M Andreansky, I C Nicholson, C-H Pui, T L Geiger, D Campana. Leukemia 2004
449
8

The basic principles of chimeric antigen receptor design.
Michel Sadelain, Renier Brentjens, Isabelle Rivière. Cancer Discov 2013
663
8

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.
Barbara Savoldo, Carlos Almeida Ramos, Enli Liu, Martha P Mims, Michael J Keating, George Carrum, Rammurti T Kamble, Catherine M Bollard, Adrian P Gee, Zhuyong Mei,[...]. J Clin Invest 2011
662
8

CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade.
Theodoros Giavridis, Sjoukje J C van der Stegen, Justin Eyquem, Mohamad Hamieh, Alessandra Piersigilli, Michel Sadelain. Nat Med 2018
415
8

CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity.
Elad Jacoby, Sang M Nguyen, Thomas J Fountaine, Kathryn Welp, Berkley Gryder, Haiying Qin, Yinmeng Yang, Christopher D Chien, Alix E Seif, Haiyan Lei,[...]. Nat Commun 2016
201
8

Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.
James N Kochenderfer, Robert P T Somerville, Tangying Lu, Victoria Shi, Adrian Bot, John Rossi, Allen Xue, Stephanie L Goff, James C Yang, Richard M Sherry,[...]. J Clin Oncol 2017
282
8

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor.
John Maher, Renier J Brentjens, Gertrude Gunset, Isabelle Rivière, Michel Sadelain. Nat Biotechnol 2002
576
8

Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans.
Michael C Jensen, Leslie Popplewell, Laurence J Cooper, David DiGiusto, Michael Kalos, Julie R Ostberg, Stephen J Forman. Biol Blood Marrow Transplant 2010
351
8

IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor.
Keishi Adachi, Yosuke Kano, Tomohiko Nagai, Namiko Okuyama, Yukimi Sakoda, Koji Tamada. Nat Biotechnol 2018
205
8

OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4(+) T cells.
Andreas A Hombach, Johannes Heiders, Marcel Foppe, Markus Chmielewski, Hinrich Abken. Oncoimmunology 2012
108
8

A safe and potent anti-CD19 CAR T cell therapy.
Zhitao Ying, Xue F Huang, Xiaoyu Xiang, Yanling Liu, Xi Kang, Yuqin Song, Xiaokai Guo, Hanzhi Liu, Ning Ding, Tingting Zhang,[...]. Nat Med 2019
140
8

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.
Jeremy S Abramson, M Lia Palomba, Leo I Gordon, Matthew A Lunning, Michael Wang, Jon Arnason, Amitkumar Mehta, Enkhtsetseg Purev, David G Maloney, Charalambos Andreadis,[...]. Lancet 2020
163
8

A versatile system for rapid multiplex genome-edited CAR T cell generation.
Jiangtao Ren, Xuhua Zhang, Xiaojun Liu, Chongyun Fang, Shuguang Jiang, Carl H June, Yangbing Zhao. Oncotarget 2017
180
7

Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b.
John A Craddock, An Lu, Adham Bear, Martin Pule, Malcolm K Brenner, Cliona M Rooney, Aaron E Foster. J Immunother 2010
303
7

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy.
Christian S Hinrichs, Rosanne Spolski, Chrystal M Paulos, Luca Gattinoni, Keith W Kerstann, Douglas C Palmer, Christopher A Klebanoff, Steven A Rosenberg, Warren J Leonard, Nicholas P Restifo. Blood 2008
286
7

A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells.
Xiuli Wang, Wen-Chung Chang, ChingLam W Wong, David Colcher, Mark Sherman, Julie R Ostberg, Stephen J Forman, Stanley R Riddell, Michael C Jensen. Blood 2011
348
7

Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells.
Saba Ghassemi, Selene Nunez-Cruz, Roddy S O'Connor, Joseph A Fraietta, Prachi R Patel, John Scholler, David M Barrett, Stefan M Lundh, Megan M Davis, Felipe Bedoya,[...]. Cancer Immunol Res 2018
83
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.